Dassault’s Manufacturing Solution Selected by Singapore Endoscope Manufacturer

Earlier this year, French 3-D technology and product lifecycle management company Dassault Systèmes unveiled a new electronic initiative aimed at helping medtech firms create fully-traceable, compliant product development processes that can expedite time to market and minimize regulatory overhead.

The “Licensed to Cure” initiative has now been selected by Olympus Technologies Singapore Pte. Ltd., an endoscope manufacturer, for the development of its medical devices. Olympus has standard operating procedures already in place for developing engineering and software system documentation for its medical device manufacturing.

Licensed to Cure is hoped to help them simplify those procedures by providing a single source of information to always get relevant, up-to-date information and establish true collaboration with the same, accurate set of product data. “Dassault Systèmes’ 3DEXPERIENCE platform gives us centralized control and management of all product lifecycle information, enabling real-time sharing and collaboration for all functions,” said Lim HN, managing director of Olympus Technologies Singapore.

“Being able to combine engineering, quality, and regulatory compliance business processes, we have moved closer towards becoming the R&D and manufacturing center of choice for our customers.” “The shifting financial, regulatory, and globalization landscapes faced by medical devices manufacturers really call for a comprehensive business experience that can keep up with complexity, lower cost, quality, and compliance at once,” said Monica Menghini, executive vice president of industry and marketing at Dassault.

“Our new Licensed to Cure industry solution experience is exactly meeting this challenge by allowing companies like Olympus Technologies Singapore to manage their business objectives in a complex regulatory environment while meeting consumers’ expectations for safe products.”

At the system’s launch on Oct. 2 during AdvaMed’s annual conference this year in Boston, Mass., Dassault’s Vice President of Life Sciences Jean Colombel said, “This solution ensures that the information is the most up-to-date. Suppose you decide to change something like the size of a piece of tubing, from 3 centimeters to 2 centimeters. This solution ensures that everyone knows about that change. The supplier would be aware of it immediately rather than at the end of the development cycle.” –